Product Code: IRTNTR44413
Technavio has been monitoring the pre-filled syringes market and it is poised to grow by $ 4.23 bn during 2020-2024 progressing at a CAGR of 13% during the forecast period. Our reports on pre-filled syringes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption by pharmaceutical companies and favorable regulations and guidelines. In addition, increasing adoption by pharmaceutical companies is anticipated to boost the growth of the market as well.
The pre-filled syringes market analysis includes material segment and geographic landscapes
Technavio's ‘pre-filled syringes market ’ is segmented as below:
By Material:
- Glass pre-filled syringes
- Plastic pre-filled syringes
By Geographic Landscape:
- Europe
- North America
- APAC
- ROW
This study identifies the increasing number of biopharmaceuticals as one of the prime reasons driving the pre-filled syringes market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our pre-filled syringes market covers the following areas:
- Pre-filled syringes market sizing
- Pre-filled syringes market forecast
- Pre-filled syringes market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pre-filled syringes market vendors that include Baxter International Inc., Becton, Dickinson and Co., Recipharm AB, Fresenius SE & Co. KGaA, Medtronic Plc, Mylan NV, Nipro Corp., Novartis AG, SCHOTT AG, and Terumo Corp. Also, the pre-filled syringes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Material
- Market segments
- Comparison by Material
- Glass pre-filled syringes - Market size and forecast 2019-2024
- Plastic pre-filled syringes - Market size and forecast 2019-2024
- Market opportunity by Material
Market Segmentation by Application
- Insulin pre-filled syringes
- Vaccine pre-filled syringes
- Anticoagulant pre-filled syringes
- Others
Market Segmentation by End-user
- Hospitals and clinics
- Home healthcare
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- Europe - Market size and forecast 2019-2024
- North America - Market size and forecast 2019-2024
- APAC - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume drivers - Demand led growth
- Volume driver - External factors
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Baxter International Inc.
- Recipharm AB
- Fresenius SE & Co. KGaA
- Medtronic Plc
- Mylan NV
- Nipro Corp.
- Novartis AG
- SCHOTT AG
- Terumo Corp.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Exhibit
- 1: Key Finding 1
- 2: Key Finding 2
- 3: Key Finding 3
- 4: Key Finding 5
- 5: Key Finding 6
- 6: Key Finding 7
- 7: Key Finding 8
- 8: Parent market
- 9: Market characteristics
- 10: Offerings of vendors included in the market definition
- 11: Market segments
- 12: Global - Market size and forecast 2019 - 2024 ($ million)
- 13: Global market: Year-over-year growth 2019 - 2024 (%)
- 14: Five forces analysis 2019 & 2024
- 15: Bargaining power of buyers
- 16: Bargaining power of suppliers
- 17: Threat of new entrants
- 18: Threat of substitutes
- 19: Threat of rivalry
- 20: Market condition - Five forces 2019
- 21: Glass pre-filled syringes - Market size and forecast 2019-2024 ($ million)
- 22: Glass pre-filled syringes - Year-over-year growth 2019-2024 (%)
- 23: Plastic pre-filled syringes - Market size and forecast 2019-2024 ($ million)
- 24: Plastic pre-filled syringes - Year-over-year growth 2019-2024 (%)
- 25: Customer landscape
- 26: Impact of drivers and challenges
- 27: Vendor landscape
- 28: Landscape disruption
- 29: Industry risks
- 30: Vendors covered
- 31: Market positioning of vendors
- 32: Baxter International Inc. - Overview
- 33: Baxter International Inc. - Business segments
- 34: Baxter International Inc. - Key offerings
- 35: Baxter International Inc. - Key customers
- 36: Baxter International Inc. - Segment focus
- 37: Becton, Dickinson and Co. - Overview
- 38: Becton, Dickinson and Co. - Business segments
- 39: Becton, Dickinson and Co. - Key offerings
- 40: Becton, Dickinson and Co. - Key customers
- 41: Becton, Dickinson and Co. - Segment focus
- 42: Recipharm AB - Overview
- 43: Recipharm AB - Business segments
- 44: Recipharm AB - Key offerings
- 45: Recipharm AB - Key customers
- 46: Recipharm AB - Segment focus
- 47: Fresenius SE & Co. KGaA - Overview
- 48: Fresenius SE & Co. KGaA - Business segments
- 49: Fresenius SE & Co. KGaA - Key offerings
- 50: Fresenius SE & Co. KGaA - Key customers
- 51: Fresenius SE & Co. KGaA - Segment focus
- 52: Medtronic Plc - Overview
- 53: Medtronic Plc - Business segments
- 54: Medtronic Plc - Key offerings
- 55: Medtronic Plc - Key customers
- 56: Medtronic Plc - Segment focus
- 57: Mylan NV - Overview
- 58: Mylan NV - Business segments
- 59: Mylan NV - Key offerings
- 60: Mylan NV - Key customers
- 61: Mylan NV - Segment focus
- 62: Nipro Corp. - Overview
- 63: Nipro Corp. - Business segments
- 64: Nipro Corp. - Key offerings
- 65: Nipro Corp. - Key customers
- 66: Nipro Corp. - Segment focus
- 67: Novartis AG - Overview
- 68: Novartis AG - Business segments
- 69: Novartis AG - Key offerings
- 70: Novartis AG - Key customers
- 71: Novartis AG - Segment focus
- 72: SCHOTT AG - Overview
- 73: SCHOTT AG - Business segments
- 74: SCHOTT AG - Key offerings
- 75: SCHOTT AG - Key customers
- 76: SCHOTT AG - Segment focus
- 77: Terumo Corp. - Overview
- 78: Terumo Corp. - Business segments
- 79: Terumo Corp. - Key offerings
- 80: Terumo Corp. - Key customers
- 81: Terumo Corp. - Segment focus
- 82: Currency conversion rates for US$
- 83: Research Methodology
- 84: Validation techniques employed for market sizing
- 85: Information sources
- 86: List of abbreviations